Mullen Scales of Early Learning: The Utility in Assessing Children Diagnosed With Autism Spectrum Disorders, Cerebral Palsy, and Epilepsy
Mullen Scales of Early Learning: The Utility in Assessing Children Diagnosed With Autism Spectrum Disorders, Cerebral Palsy, and Epilepsy
复制标题
DOI：
10.1080/21622965.2012.682852
复制
发表时间：
2013-01-01
影响因子：
1.7
通讯作者：
Spencer, Katherine S.
中科院分区：
文献类型：
--
作者：
Burns, Thomas G.;King, Tricia Z.;Spencer, Katherine S.
一组47名被诊断为神经发育障碍的患者与47名年龄、性别和种族匹配的典型发育儿童进行比较，以检查马伦早期学习量表（MSEL）各领域的损伤频率。MSEL是一项认知功能的综合指标，旨在评估出生至68个月的婴儿和学龄前儿童。在神经发育组中，样本由2至4岁的儿童组成，他们被诊断患有自闭症谱系障碍（ASD; n = 19），脑瘫（CP; n = 14）和癫痫（EPI; n = 14）。从MSEL的标准样本中提取的47个匹配对照样本用作对照组。相对于相应的匹配对照组，包含神经发育样品的每一个临床组都表现出跨域的统计学显著延迟（p < .001）。儿童未能表现出ASD、CP或EPI诊断的“特征”。的临床敏感性的MSEL和需要获得特定的干预服务，诊断为这些条件的儿童。最后，这些结果进行了讨论的上下文中的临床敏感性的MSEL在这些临床人群。
A group of 47 patients diagnosed with neurodevelopmental disorders were compared to 47 age-, gender-, and racially matched typically developing children to examine the frequency of impairment across domains of the Mullen Scales of Early Learning (MSEL). The MSEL is a comprehensive measure of cognitive functioning designed to assess infants and preschool children between the ages of birth to 68 months. In the neurodevelopmental group, the sample was composed of children 2 to 4 years of age who were diagnosed with autism spectrum disorders (ASD; n = 19), cerebral palsy (CP; n = 14), and epilepsy (EPI; n = 14). A sample of 47 matched controls, taken from the normative sample of the MSEL, was used as a comparison group. Each one of the clinical groups comprising the neurodevelopmental sample demonstrated statistically significant delays across domains relative to the respective matched control group (p < .001). Children failed to demonstrate a "signature" profile for a diagnosis of ASD, CP, or EPI. The clinical sensitivity of the MSEL and the need for obtaining specific intervention services for children diagnosed with these conditions are presented. Finally, these results are discussed within the context of the clinical sensitivity of the MSEL in working with these clinical populations.